Source: Anti-Cancer Drugs. Unidade: FMVZ
Subjects: MELANOMA, INIBIDORES DE ENZIMAS, REPOSICIONAMENTO DE FÁRMACOS
ABNT
NASCIMENTO, Rodrigo S. do et al. Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing. Anti-Cancer Drugs, v. 32, n. 2, p. 111-116, 2021Tradução . . Disponível em: https://doi.org/10.1097/CAD.0000000000001013. Acesso em: 13 nov. 2024.APA
Nascimento, R. S. do, Nagamine, M. K., Toledo, G. F. de, Chaible, L. M., Tedardi, M. V., Del-Grande, M. P., et al. (2021). Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing. Anti-Cancer Drugs, 32( 2), 111-116. doi:10.1097/CAD.0000000000001013NLM
Nascimento RS do, Nagamine MK, Toledo GF de, Chaible LM, Tedardi MV, Del-Grande MP, Fonseca IIM da, Dagli MLZ. Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing [Internet]. Anti-Cancer Drugs. 2021 ; 32( 2): 111-116.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1097/CAD.0000000000001013Vancouver
Nascimento RS do, Nagamine MK, Toledo GF de, Chaible LM, Tedardi MV, Del-Grande MP, Fonseca IIM da, Dagli MLZ. Sodium dichloroacetate attenuates the growth of B16-F10 melanoma in vitro and in vivo: an opportunity for drug repurposing [Internet]. Anti-Cancer Drugs. 2021 ; 32( 2): 111-116.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1097/CAD.0000000000001013